Evaluating the role of life events and sustaining conditions in weight loss maintenance

Journal of Obesity

Volumn 2010, Issue , 2010, Pages

  Epiphaniou, Eleni ^a   Ogden, Jane ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883313291     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2010/859413     Document Type: Article

References (52)

1. Fong D. S., Aiello L. P., Ferris F. L. III, Klein R., Diabetic retinopathy. Diabetes Care 2004 27 10 2540 2553 2-s2.0-4644316459 10.2337/diacare.27.10.2540 (Pubitemid 39281419)
2. Mizutani M., Kern T. S., Lorenzi M., Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Journal of Clinical Investigation 1996 97 12 2883 2890 2-s2.0-0029973474 (Pubitemid 26197103)
3. Kern T. S., Tang J., Mizutani M., Kowluru R. A., Nagaraj R. H., Romeo G., Podesta F., Lorenzi M., Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Investigative Ophthalmology and Visual Science 2000 41 12 3972 3978 2-s2.0-0033753702
4. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 329 14 977 986 2-s2.0-0027370108 10.1056/NEJM199309303291401 (Pubitemid 23307905)
5. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998 352 9131 837 853 2-s2.0-0032511580 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
6. Kowluru R. A., Chan P.-S., Oxidative stress and diabetic retinopathy. Experimental Diabetes Research 2007 2007 1 12 2-s2.0-34247394257 10.1155/2007/43603 (Pubitemid 46630110)
7. Niedowicz D. M., Daleke D. L., The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics 2005 43 2 289 330 2-s2.0-23244451614 10.1385/CBB:43:2:289 (Pubitemid 41095268)
8. Nishikawa T., Edelstein D., Du X. L., Yamagishi S.-I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H.-P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
9. Brandes R. P., Kreuzer J., Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovascular Research 2005 65 1 16 27 2-s2.0-11144338749 10.1016/j.cardiores.2004.08.007 (Pubitemid 40038475)
10. Stolk J., Hiltermann T. J., Dijkman J. H., Verhoeven A. J., Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. American Journal of Respiratory Cell and Molecular Biology 1994 11 1 95 102 2-s2.0-0028473441
11. James A. M., Cochemé H. M., Murphy M. P., Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mechanisms of Ageing and Development 2005 126 9 982 986 2-s2.0-22744448180 10.1016/j.mad.2005.03.026 (Pubitemid 41033179)
12. Chibber R., Molinatti P. A., Rosatto N., Lambourne B., Kohner E. M., Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 1997 40 2 156 164 2-s2.0-0031019299 10.1007/s001250050657 (Pubitemid 27060287)
13. Gurtu V., Kain S. R., Zhang G., Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Analytical Biochemistry 1997 251 1 98 102 2-s2.0-0031571676 10.1006/abio.1997.2220 (Pubitemid 27352149)
14. Zhao H., Joseph J., Fales H. M., Sokoloski E. A., Levine R. L., Vasquez-Vivar J., Kalyanaraman B., Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proceedings of the National Academy of Sciences of the United States of America 2005 102 16 5727 5732 2-s2.0-17644394600 10.1073/pnas. 0501719102 (Pubitemid 40559627)
15. Carter W. O., Narayanan P. K., Robinson J. P., Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. Journal of Leukocyte Biology 1994 55 2 253 258
16. Chibber R., Molinatti P. A., Kohner E. M., Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cellular and Molecular Biology 1999 45 1 47 57
17. Beltramo E., Berrone E., Buttiglieri S., Porta M., Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes/Metabolism Research and Reviews 2004 20 4 330 336 2-s2.0-4043179699 10.1002/dmrr.470 (Pubitemid 39077484)
18. Manea A., Constantinescu E., Popov D., Raicu M., Changes in oxidative balance in rat pericytes exposed to diabetic conditions. Journal of Cellular and Molecular Medicine 2004 8 1 117 126 2-s2.0-3142718936 (Pubitemid 44145529)
19. Kowluru R. A., Koppolu P., Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radical Research 2002 36 9 993 999 2-s2.0-0036023314 10.1080/1071576021000006572 (Pubitemid 34863646)
20. Pomero F., Allione A., Beltramo E., Buttiglieri S., D'Alù F., Ponte E., Lacaria A., Porta M., Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes. Diabetologia 2003 46 3 416 419 2-s2.0-0038642030 (Pubitemid 36547598)
21. Abu El-Asrar A. M., Dralands L., Missotten L., Al-Jadaan I. A., Geboes K., Expression of apoptosis markers in the retinas of human subjects with diabetes. Investigative Ophthalmology and Visual Science 2004 45 8 2760 2766 2-s2.0-3242884227 10.1167/iovs.03-1392 (Pubitemid 38998875)
22. Mohr S., Xi X., Tang J., Kern T. S., Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002 51 4 1172 1179 2-s2.0-0036224782 (Pubitemid 34438365)
23. Cacicedo J. M., Benjachareowong S., Chou E., Ruderman N. B., Ido Y., Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 2005 54 6 1838 1845 2-s2.0-20044386906 10.2337/diabetes.54.6.1838 (Pubitemid 40770775)
24. Manea A., Raicu M., Simionescu M., Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose. Biology of the Cell 2005 97 9 723 734 2-s2.0-25144456043 10.1042/BC20040107 (Pubitemid 41335165)
25. Cheng G., Cao Z., Xu X., van Meir E. G., Lambeth J. D., Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001 269 1-2 131 140 2-s2.0-0035897653 10.1016/S0378-1119(01)00449-8 (Pubitemid 32488913)
26. Bayraktutan U., Blayney L., Shah A. M., Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 8 1903 1911 2-s2.0-0033897196 (Pubitemid 30644639)
27. Li J.-M., Shah A. M., Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. Journal of Biological Chemistry 2002 277 22 19952 19960 2-s2.0-0037205457 10.1074/jbc.M110073200 (Pubitemid 34967517)
28. Asaba K., Tojo A., Onozato M. L., Goto A., Quinn M. T., Fujita T., Wilcox C. S., Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney International 2005 67 5 1890 1898 2-s2.0-17744364508 10.1111/j.1523-1755.2005. 00287.x (Pubitemid 40577724)
29. Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Kobayashi K., Kuroda J., Sumimoto H., Nawata H., Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 2003 46 10 1428 1437 2-s2.0-0042864155 10.1007/s00125-003-1205-6 (Pubitemid 37297214)
30. Guzik T. J., West N. E., Black E., McDonald D., Ratnatunga C., Pillai R., Channon K. M., Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circulation Research 2000 86 9 E85 E90 2-s2.0-0034640107
31. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., Dandona P., Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. Journal of Clinical Endocrinology and Metabolism 2000 85 8 2970 2973 2-s2.0-0034455878 10.1210/jc.85.8.2970 (Pubitemid 32269184)
32. Inoguchi T., Li P., Umeda F., Yu H. Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H., High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 11 1939 1945 2-s2.0-0033765672
33. DeCoursey T. E., Ligeti E., Regulation and termination of NADPH oxidase activity. Cellular and Molecular Life Sciences 2005 62 19-20 2173 2193 2-s2.0-27144535425 10.1007/s00018-005-5177-1 (Pubitemid 41500537)
34. Fontayne A., Dang P. M.-C., Gougerot-Pocidalo M.-A., El Benna J., Phosphorylation of p47phox sites by PKC α β II, δ and ζ: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 2002 41 24 7743 7750 2-s2.0-0037129803 10.1021/bi011953s (Pubitemid 34627801)
35. Agardh C.-D., Hultberg B., Nayak R. C., Farthing-Nayak P., Agardh E., Bovine retinal pericytes are resistant to glucose-induced oxidative stress in vitro. Antioxidants and Redox Signaling 2005 7 11-12 1486 1493 2-s2.0-28844503196 10.1089/ars.2005.7.1486 (Pubitemid 41767984)
36. Ouslimani N., Peynet J., Bonnefont-Rousselot D., Thérond P., Legrand A., Beaudeux J.-L., Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 2005 54 6 829 834 2-s2.0-19444380162 10.1016/j.metabol.2005.01.029 (Pubitemid 40725333)
37. Tawfik A., Sanders T., Kahook K., Akeel S., Elmarakby A., Al-Shabrawey M., Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase. Investigative Ophthalmology & Visual Science 2009 50 2 878 884 2-s2.0-59449102868
38. Al-Shabrawey M., Rojas M., Sanders T., Behzadian A., El-Remessy A., Bartoli M., Parpia A. K., Liou G., Caldwell R. B., Role of NADPH oxidase in retinal vascular inflammation. Investigative Ophthalmology and Visual Science 2008 49 7 3239 3244 2-s2.0-48249134698 10.1167/iovs.08-1755
39. Al-Shabrawey M., Bartoli M., El-Remessy A. B., Ma G., Matragoon S., Lemtalsi T., Caldwell R. W., Caldwell R. B., Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Investigative Ophthalmology and Visual Science 2008 49 7 3231 3238 2-s2.0-48249088030 10.1167/iovs.08-1754
40. Yano M., Hasegawa G., Ish M. II, Yamasaki M., Fukui M., Nakamura N., Yoshikawa T., Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Report 2004 9 2 111 116 2-s2.0-3543026291 10.1179/135100004225004779 (Pubitemid 39010936)
41. Tojo A., Asaba K., Onozato M. L., Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opinion on Therapeutic Targets 2007 11 8 1011 1018 2-s2.0-34547788748 10.1517/14728222.11.8.1011 (Pubitemid 47232619)
42. Susztak K., Raff A. C., Schiffer M., Böttinger E. P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 55 1 225 233 2-s2.0-33644783770 10.2337/diabetes.55.1.225 (Pubitemid 43343319)
43. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D., The release of cytochrome c from mitochondria: a primary site for Bcl- 2 regulation of apoptosis. Science 1997 275 5303 1132 1136 2-s2.0-0031037897 10.1126/science.275.5303.1132 (Pubitemid 27097313)
44. Anderson M. M., Heinecke J. W., Production of N ε -(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes 2003 52 8 2137 2143 2-s2.0-0042915798 10.2337/diabetes.52.8.2137 (Pubitemid 36919809)
45. Schleicher E. D., Wagner E., Nerlich A. G., Increased accumulation of the glycoxidation product N(ε)- (carboxymethyl)lysine in human tissues in diabetes and aging. Journal of Clinical Investigation 1997 99 3 457 468 2-s2.0-0030763201 (Pubitemid 27414803)
46. Berrone E., Beltramo E., Solimine C., Ape A. U., Porta M., Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. Journal of Biological Chemistry 2006 281 14 9307 9313 2-s2.0-33646938091 10.1074/jbc.M600418200 (Pubitemid 43864646)
47. Zhang J.-Z., Gao L., Widness M., Xi X., Kern T. S., Captopril inhibits glucose accumulation in retinal cells in diabetes. Investigative Ophthalmology and Visual Science 2003 44 9 4001 4005 2-s2.0-0042361953 10.1167/iovs.02-1193 (Pubitemid 37047975)
48. Nagai R., Ikeda K., Higashi T., Sano H., Jinnouchi Y., Araki T., Horiuchi S., Hydroxyl radical mediates Nε -(carboxymethyl)lysine formation from Amadori product. Biochemical and Biophysical Research Communications 1997 234 1 167 172 2-s2.0-0030966609 10.1006/bbrc.1997.6608 (Pubitemid 27267554)
49. Wells-Knecht K. J., Zyzak D. V., Litchfield J. E., Thorpe S. R., Baynes J. W., Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995 34 11 3702 3709 2-s2.0-0028951461 10.1021/bi00011a027
50. Cervantes-Laurean D., Roberts M. J., Jacobson E. L., Jacobson M. K., Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment. Free Radical Biology and Medicine 2005 38 6 786 795 2-s2.0-13844255024 10.1016/j.freeradbiomed.2004.11. 030 (Pubitemid 40249749)
51. Hammes H.-P., Alt A., Niwa T., Clausen J. T., Bretzel R. G., Brownlee M., Schleicher E. D., Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 1999 42 6 728 736 2-s2.0-0033028542 10.1007/s001250051221 (Pubitemid 29265591)
52. Hammes H.-P., Brownlee M., Lin J., Schleicher E., Bretzel R. G., Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N ε -(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 1999 42 5 603 607 2-s2.0-0032968131 10.1007/s001250051201 (Pubitemid 29196012)